BlueRock Therapeutics and bit.bio’s Collaboration and Option Agreement

Pietro Martinoia North America Legal Chronicle
Tagged:

Goodwin advised bit.bio on the agreement.BlueRock Therapeutics LP, a wholly owned, independently operated subsidiary of Bayer AG, and bit.bio announced a collaboration and option agreement for the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here